Filter by Year:
Press Releases
-
Aug 10, 2021
Foghorn Therapeutics Provides Second Quarter 2021 Corporate Update
-
Aug 03, 2021
Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference
-
Jul 09, 2021
Foghorn Therapeutics to Participate at the William Blair Biotech Focus Conference 2021
-
Jun 08, 2021
Foghorn Therapeutics to Host Research & Development Day Webinar on June 15th
-
May 26, 2021
Foghorn Therapeutics to Present in Two Upcoming Investor Conferences
-
May 17, 2021
Foghorn Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Program of FHD-286
-
May 11, 2021
Foghorn Therapeutics Provides Corporate Update
-
Apr 28, 2021
Foghorn Therapeutics Appoints Ian Smith to its Board of Directors
-
Mar 18, 2021
Foghorn Therapeutics Provides Corporate Update
-
Mar 11, 2021
UPDATE: Foghorn Therapeutics to Present Poster and Chair a Panel at the AACR Annual Meeting 2021
Displaying 51 - 60 of 69